Physician profile
Mark A Babbitt
NPI 1962425454
$1,153.61
in general payments reported to CMS, 2019-2025
9 companies · $290 in 2025
The $290 reported for 2025 was more than what 82% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $204 · 2021: $37.95 · 2022: $79.21 · 2023: $56.00 · 2024: $209 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $415 · Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $415.47 |
| Food and Beverage | $139.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $430.34 | 2019-2024 | Invisalign, Itero Element 5d Plus, Itero Element 5d Plus Mobile |
| Ultradent Products INC | $415.47 | 2024-2025 | Opalescence |
| Nobel Biocare USA | $128.69 | 2019-2020 | |
| Coltene Whaledent INC. | $75.00 | 2019 | |
| Kerr Corporation | $37.95 | 2021 | |
| Implant Direct Sybron International LLC | $37.41 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $14.53 | 2023 | |
| Salvin Dental Specialties, INC. | $8.51 | 2019 | |
| Biolase, INC. | $5.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Babbitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.